Neuromodulation Market by Application (Parkinson’s, Ischemia, Chronic Pain, Epilepsy, Depression, Tremor, Migraine), Technology- Internal (Vagus Nerve Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation) – 2020 to 2025

$3,850.00$5,850.00

Published on: March 24, 2020
Clear
SKU: GMS-2115 Category:

OVERVIEW

The global market for neuromodulation is expected to hit USD 8.8 billion by 2025, rising between 2020 and 2025 at a CAGR of 8.62%. Growing the prevalence of neurological disorders, growing research into expanding neuromodulation applications, and understanding of neurodegenerative disorders drives the growth of this sector.

Neuromodulation Market by Application (Parkinson’s, Ischemia, Chronic Pain, Epilepsy, Depression, Tremor, Migraine), Technology- Internal (Vagus Nerve Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation) - 2020 to 2025 1

Neuromodulation Market by Application (Parkinson’s, Ischemia, Chronic Pain, Epilepsy, Depression, Tremor, Migraine), Technology- Internal (Vagus Nerve Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation) - 2020 to 2025 2

Neuromodulation Market by Application (Parkinson’s, Ischemia, Chronic Pain, Epilepsy, Depression, Tremor, Migraine), Technology- Internal (Vagus Nerve Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation) - 2020 to 2025 3

Neuromodulation Market by Application (Parkinson’s, Ischemia, Chronic Pain, Epilepsy, Depression, Tremor, Migraine), Technology- Internal (Vagus Nerve Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation) - 2020 to 2025 4

Neuromodulation Market by Application (Parkinson’s, Ischemia, Chronic Pain, Epilepsy, Depression, Tremor, Migraine), Technology- Internal (Vagus Nerve Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation) - 2020 to 2025 5

Neuromodulation Market by Application (Parkinson’s, Ischemia, Chronic Pain, Epilepsy, Depression, Tremor, Migraine), Technology- Internal (Vagus Nerve Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation) - 2020 to 2025 6

Neuromodulation Market by Application (Parkinson’s, Ischemia, Chronic Pain, Epilepsy, Depression, Tremor, Migraine), Technology- Internal (Vagus Nerve Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation) - 2020 to 2025 7

Neuromodulation Market by Application (Parkinson’s, Ischemia, Chronic Pain, Epilepsy, Depression, Tremor, Migraine), Technology- Internal (Vagus Nerve Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation) - 2020 to 2025 8

TABLE OF CONTENT

1 Global Neuromodulation Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Neuromodulation Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Neuromodulation Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Neuromodulation Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Neuromodulation Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Neuromodulation Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Neuromodulation Market – By Technology (Market Size – & million/billion)
8.1 Internal Neuromodulation
8.2 External Neuromodulation

9 Global Neuromodulation Market – By Application
9.1 Spinal Cord Stimulation
9.2 Deep Brain Stimulation
9.3 Vagus Nerve Stimulation
9.4 Sacral Nerve Stimulation
9.5 Transcutaneous Electrical Nerve Stimulation
9.6 Gastric Electrical Stimulation
9.7 Respiratory Electrical Stimulation
9.8 Others

10 Global Neuromodulation Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa

11 Global Neuromodulation Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships

12 Global Neuromodulation Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Medtronic
12.3 Abbott
12.4 Boston Scientific Corporation
12.5 Biocontrol Medical
12.6 Synapse Biomedical
12.7 Neuronetics
12.8 Livanova
12.9 Nevro Corporation
12.10 Neurosigma, Inc.
12.11 Neuropace, Inc.
12.12 Company 11 & more

13 Global Neuromodulation Market – Appendix
13.1 Sources
13.2 Abbreviations